Financials

News Ideas Technicals Forecast

SONN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sonnet BioTherapeutics Holdings, Inc.

Total assets of SONN for Q2 24 is 5.91 M USD, 10.71% more than the previous Q1 24. And total liabilities increased by 3.25% in Q2 24 to 2.86 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—